Education
About Us
Working with TipRanks
Follow Us
Lenz Therapeutics, Inc. (LENZ)
:LENZ
Earnings Data
Report Date
May 07, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.55Last Year’s EPS
-3.53Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 19, 2025
|% Change Since: 4.47%
|Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with significant achievements in regulatory progress, financial health, and commercial preparation. Despite some challenges such as increased expenses and delayed market availability post-approval, the overall outlook remains optimistic with strong consumer interest and strategic positioning in the presbyopia market.Company Guidance
In the recent call, LENZ Therapeutics provided a detailed overview of its 2024 progress and outlined key metrics guiding its future outlook. The company concluded 2024 with a robust cash position of over $209 million, ensuring a solid financial runway towards the anticipated launch of LNZ100. Key milestones included the completion of the Phase 3 CLARITY study, a $30 million financing deal, and the acceptance of their NDA in October. Looking ahead, LENZ is targeting an August 2025 FDA approval, with commercial launch activities planned for Q4 2025. The company has made significant strides in regulatory processes, manufacturing readiness, and pre-launch commercial planning, having hired their sales force and conducted over 1,000 engagements with eye care professionals. With a market opportunity estimated at over $3 billion in the U.S. alone, LENZ aims to leverage its innovative LNZ100 product to capture a substantial share of the presbyopia treatment market.Successful Year and Financial Position
LENZ Therapeutics reported a successful year in 2024, transitioning to a pre-commercial company with a strong financial position, ending with over $209 million in cash.
Regulatory Progress and Manufacturing Readiness
Made encouraging progress with the FDA on NDA review with no significant issues noted and manufacturing readiness achieved with initial commercial production started in February.
Medical Engagement and Intellectual Property
Engaged over 1,000 eye care professionals (ECPs) and strengthened patent estate with seven granted patents in the U.S., aiming for protection until at least 2044.
Pre-launch Commercial Strategy
Finalized the hiring of sales force leadership, attracted over 1,300 applications within 24 hours for 88 territory sales roles, and launched an unbranded campaign reaching over 30,000 ECPs with 2 million digital impressions.
Strong Consumer Interest
Phase 3 CLARITY study showed 90% of participants noticed vision improvement, with 75% indicating they would continue using LNZ100, highlighting significant consumer interest.
---
LENZ Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
LENZ Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 19, 2025 | $25.52 | $26.30 | +3.06% |
| Nov 06, 2024 | $28.65 | $32.23 | +12.50% |
| Aug 14, 2024 | $23.50 | $22.60 | -3.83% |
| May 08, 2024 | $16.18 | $15.40 | -4.82% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Lenz Therapeutics, Inc. (LENZ) report earnings?
Lenz Therapeutics, Inc. (LENZ) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
What is Lenz Therapeutics, Inc. (LENZ) earnings time?
Lenz Therapeutics, Inc. (LENZ) earnings time is at May 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LENZ EPS forecast?
LENZ EPS forecast for the fiscal quarter 2025 (Q1) is -0.55.
---